- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-43-0038439

Pronghorn Medipharma Private Limited
About Pronghorn Medipharma Private Limited
Data last updated:
Pronghorn Medipharma Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 13 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24290UP2021PTC143412.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Kumar Agnihotri and Anjali Agnihotri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Keshav Complex New Sabji Mandi Chaubepur, Kanpur, Uttar Pradesh, India – 209203.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.84 Cr, a growth of 121% compared to the previous year. For the same year it recorded a net profit of ₹15.55 Lakh (net margin 8.5%) and EBITDA of ₹27.14 Lakh (EBITDA margin 14.8%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Pronghorn Medipharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0038439). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Pronghorn Medipharma
Contact details
Pronghorn Medipharma Private Limited's registered office is in Kanpur, Uttar Pradesh.
- Registered AddressKeshav Complex New Sabji Mandi Chaubepur, Kanpur, Uttar Pradesh, India – 209203
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Pronghorn Medipharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Pronghorn Medipharma Private Limited, buy the company report.
Financials of Pronghorn Medipharma Private Limited
FY 2025 filings availablePronghorn Medipharma Private Limited reported revenue of ₹1.84 Cr (up 121% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 121% in the latest year. EBITDA rose 107% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹27.14 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹15.55 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 14.8% | |||
| Net Profit Margin | 8.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Pronghorn Medipharma Private Limited, buy the company report.
Board of directors of Pronghorn Medipharma Private Limited
Pronghorn Medipharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Kumar Agnihotri | Director | 13 Mar 2021 | 5 Years 7 Months | Current |
| Anjali Agnihotri | Director | 13 Mar 2021 | 5 Years 7 Months | Current |
Peer comparison
Pronghorn Medipharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Spitfire Hygiene Products Private Limited | ₹1.84 Cr (FY 2025) | -4.0% | Mewat, Haryana, India | |||
| SNR Metchem Private Limited | ₹1.84 Cr (FY 2025) | 7327.0% | Modasa, Gujarat, India | |||
| Mangalore Puf Industries Private Limited | ₹1.84 Cr (FY 2023) | -12.0% | Mangalore, Karnataka, India | |||
| Adelson Life Care Private Limited | ₹1.84 Cr (FY 2024) | -10.0% | Jaipur, Rajasthan, India | |||
| Shakun Enterprises Private Limited | ₹1.84 Cr (FY 2025) | -1.0% | Bihar, India | |||
| Pronghorn Medipharma Private Limitedthis company | ₹1.84 Cr (FY 2024) | ₹15.55 Lakh | 8.5% | 121.0% | Kanpur, Uttar Pradesh, India | |
| Vishnu Poly-Chems Private Limited | ₹1.84 Cr (FY 2019) | -15.0% | Solapur, Maharashtra, India | |||
| JSR Amenities Private Limited | ₹1.83 Cr (FY 2024) | 111.0% | Delhi, India | |||
| Autoprint Formula Solutions Private Limited | ₹1.83 Cr (FY 2025) | 33.0% | Coimbatore, Tamil Nadu, India | |||
| Avery Pharmaceuticals Private Limited | ₹1.83 Cr (FY 2025) | 42.0% | Mumbai, Maharashtra, India | |||
| Vulture International Private Limited | ₹1.83 Cr (FY 2024) | 170.0% | Dewas, Madhya Pradesh, India |
To see the full peer comparison of Pronghorn Medipharma Private Limited, buy the company report.
Legal cases
Pronghorn Medipharma Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Criminal case | Filed against the company by State of Up | Pending |
To see the full case history of Pronghorn Medipharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pronghorn Medipharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Pronghorn Medipharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Pronghorn Medipharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anjali Agnihotri was appointed as Director on 13 Mar 2021.
Frequently asked questions
Pronghorn Medipharma is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 13 March 2021 (5+ years old) and is registered under CIN U24290UP2021PTC143412.
Pronghorn Medipharma has 2 current directors:
- Sandeep Kumar Agnihotri - Director
- Anjali Agnihotri - Director
The latest financial statements of Pronghorn Medipharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Pronghorn Medipharma is U24290UP2021PTC143412. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pronghorn Medipharma has 1 court case on record: 1 filed against it. 1 is pending.
Pronghorn Medipharma was incorporated on 13 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Pronghorn Medipharma by revenue are Spitfire Hygiene Products Private Limited, SNR Metchem Private Limited, Mangalore Puf Industries Private Limited, Adelson Life Care Private Limited, Shakun Enterprises Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anjali Agnihotri was appointed as Director on 13 Mar 2021. Sandeep Kumar Agnihotri was appointed as Director on 13 Mar 2021.
Yes, Pronghorn Medipharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0038439).
The registered office of Pronghorn Medipharma is at Keshav Complex New Sabji Mandi Chaubepur, Kanpur, Uttar Pradesh, India – 209203.
Pronghorn Medipharma operates in the chemicals industry, in the manufacturing segment.

